Daniel Hollyman
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
-
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- CAR-T cell therapy research 5
-
- CRISPR and Genetic Engineering 2
- Co-authors
- Isabelle Rivière (5 shared papers)Clare Taylor (3 shared papers)Michel Sadelain (5 shared papers)Renier J. Brentjens (4 shared papers)Raymond Yeh (3 shared papers)Jolanta Stefanski (3 shared papers)Ming‐Qing Du (1 shared paper)Tyson V. Sharp (1 shared paper)
- Journals
- Cytotherapy (2 papers)Journal of Clinical Oncology (1 paper)Journal of Virology (1 paper)Bone Marrow Transplantation (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Daniel Hollyman
10 papers receiving 487 citations
Peers
Comparison fields: 5 of 44
- Oncology 310
- Immunology 124
- Genetics 147
- Hematology 51
- Epidemiology 78
Countries citing papers authored by Daniel Hollyman
This map shows the geographic impact of Daniel Hollyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hollyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hollyman more than expected).
Fields of papers citing papers by Daniel Hollyman
This network shows the impact of papers produced by Daniel Hollyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hollyman. The network helps show where Daniel Hollyman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Hollyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 233 | |
| 2 | 2002 | 163 | |
| 3 | 2012 | 35 | |
| 4 | 2015 | 27 | |
| 5 | 2007 | 26 | |
| 6 | 2007 | 6 | |
| 7 | 2008 | 4 | |
| 8 | 2006 | 2 | |
| 9 | 2014 | 2 | |
| 10 | 2009 | 1 |
About Daniel Hollyman
Daniel Hollyman is a scholar working on Oncology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Hematology, having authored 10 papers that have together received 499 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), CRISPR and Genetic Engineering (2 papers), Virus-based gene therapy research (2 papers), Quality and Supply Management (1 paper) and Technology Assessment and Management (1 paper). The work is most often cited by research in Oncology (310 citations), Immunology (124 citations), Genetics (147 citations), Hematology (51 citations) and Epidemiology (78 citations). Daniel Hollyman has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Isabelle Rivière, Clare Taylor, Michel Sadelain, Renier J. Brentjens, Raymond Yeh, Jolanta Stefanski, Ming‐Qing Du, Tyson V. Sharp, Hongtao Ye and Hsei–Wei Wang. Their work appears in journals such as Cytotherapy, Journal of Clinical Oncology, Journal of Virology, Bone Marrow Transplantation and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.